Zobrazeno 1 - 10
of 206
pro vyhledávání: '"35"'
Publikováno v:
European Psychiatry; 2020, Vol. 63 Issue 1, p1-8, 8p
Autor:
C.A. Tovilla Zárate, L. Gómez Valencia, M.M. Rivera Angles, R. Molina Sólis, M.L. López Narváez, A. López López, D.Y. Bermúdez Ocaña, J.P. Sánchez de la Cruz, A. Valencia Hernández
Publikováno v:
European Psychiatry. 41:S596-S597
The attention deficit hyperactivity disorder (ADHD) is a common neuropsychiatric disease in infancy and adolescence, its world prevalence in the general population is high 3.4%. There is genetic evidence that consistently supports the polygenic natur
Autor:
G. Djokic, N. Zivkovic
Publikováno v:
European Psychiatry. 41:s809-s809
IntroductionAlthough there is no cure, schizophrenia is highly treatable disease. Successful first episode schizophrenia (FES) treatment is crucial to minimize personal, vocational and social deterioration. Quetiapine is atypical, second generation a
Publikováno v:
European Psychiatry. 41:S543-S543
ObjectivesFor a long time, cognitive deficits were considered as part of depressive episodes and were expected to improve as other affective symptoms diminished with treatment. Because of this, cognitive impairment was rarely assessed for Major depre
Autor:
Diana Silva, Ana Cristina Araújo, A.P. Amaral, M. Bajouco, Maria João Soares, Ana Telma Pereira, José Valente, António Macedo, Nuno Madeira
Publikováno v:
European Psychiatry. 33:s286-s286
IntroductionThe FMPS is a 35-item self-report questionnaire to measure perfectionism. It evaluates: concern over mistakes/CM, doubts about actions/DA, parental criticism/PC and expectations/PE, personal standards/PS and organization/O.ObjectivesTo de
Autor:
Antonio Lasalvia, F. Spagnolli, Paolo Brambilla, Veronica Marinelli, Roberto Cerini, Cinzia Perlini, S. Tosato, Nicolò Cardobi, Marcella Bellani, Umberto Castellani, Letizia Squarcina, Gianluca Rambaldelli, K. De Santi, Mirella Ruggeri, Denis Peruzzo
Publikováno v:
European Psychiatry. 30:302
Introduction Vascular changes in the brain are relevant in schizophrenia [e.g. 1] and in bipolar disorder [2]. The study of first episode psychosis (FEP) allows the analysis of brain morphology and function without confounds due to chronicity. Object
Autor:
A. Turkcan, S. Ates
Publikováno v:
European Psychiatry. 30:701
Introduction Identifying the risk factors for conduct disorder is important for the diagnosis, treatment and management of conduct problems. It is well-known that conduct disorder is associated with parental psychopathological conditions like materna
Publikováno v:
European Psychiatry. 30:1038
Introduction Anabolic Androgenic Steroids (AAS) are typically used by athletes, sports coaches and recreational sports users in an attempt to improve muscle mass and enhance sporting regimes. Despite a myriad of health problems associated with using
Autor:
K. Nagy, György Németh, Balázs Szatmári, István Laszlovszky, M. Debelle, S. Faradzs-zade, Suresh Durgam
Publikováno v:
European Psychiatry. 30:242
Introduction Cariprazine, a dopamine D 3 /D 2 receptor partial agonist with preferential binding to D 3 receptors, is being developed for the treatment of schizophreni a Objective To explore the effect of cariprazine on negative symptoms of schizophr
Publikováno v:
European Psychiatry. 29:1
Purpose The aim of this study is to assess the dependence between the obsessive-compulsive symptoms, the eating disorders symptoms and orthorexia in adolescents aged 15-19, due to define which of these areas orthorexia is closer to. The study control